Appendix 4E and 2026 Annual Report
Filed with ASX · · 95 pages · English
Summary by 6ix AI
The report indicates a net loss for the year, which is an improvement compared to the previous year, and highlights significant expenditures on technology research. No dividends were declared or paid during the reporting period, and the company continues to focus on developing its quantum computing and biochip technologies. The report also confirms that an unmodified audit report was provided by Grant Thornton Audit Pty Ltd.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Archer Materials Limited on 6ix
Story so far
Earlier from Archer Materials
- Early Pre-Pilot Study Advances Potassium Biosensor
- Biochip Advances Towards Clinical-Ready Device Development
- Archer Materials investor webinar on the IonQ partnership and Share Purchase Plan
- Archer Completes $7m Placement and Launches SPP Offer
- Presentation - Bringing Quantum Computing to Australia
Later from Archer Materials
All Archer Materials news releasesFollow Archer Materials into a list and get an email when it puts out news.
Follow Archer Materials